First Tracks Biotherapeutics, Inc. (TRAX)
Market Closed
14 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary 
XDUS $
37. 63
+1.19
+3.2656%
$
1.27B Market Cap
- P/E Ratio
- Div Yield
68,875 Volume
- Eps
$ 36.44
Previous Close Investors:
Want to track TRAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
First Tracks Biotherapeutics, Inc. (TRAX) Statistics
Valuation metrics
Market Cap 1.27B
Enterprise value 1.11B
Trailing P/E (ttm) -15.25
Forward P/E -
PEG ratio -0.15
Price/Sales (ttm) -
Price/Book (mrq) 7.64
Enterprise Value/Revenue -
Enterprise Value/EBITDA -12.67
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 619.9K
Average volume (90 days) 622.8K
Price summary
52-Week low 14.72
52-Week high 49.91
Beta -
50-Day moving average 42.54
200-Day moving average 18.88
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.46%
Return on equity -0.39%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.37
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.75
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 14.28%
Book value per share (mrq) 4.77
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
